Quantum Computing Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Quantum Computing Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $682.0K | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $373.0K | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $358.0K | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | $136.0K | Sep 11, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.0K | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $112.0K | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $162.0K | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | $75.0K | Sep 11, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.67M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($68.54M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($27.02M) | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | ($25.98M) | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | ($27.90M) | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | ($24.73M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($8.38M) | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | ($10.51M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($175.0K) | Jun 7, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($51.08M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($25.94M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($26.24M) | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | ($28.65M) | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | ($17.13M) | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | ($17.34M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.55M) | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | ($5.80M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($175.0K) | Jun 7, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.47M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $11.32M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $8.89M | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | $5.22M | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | $2.59M | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | $1.54M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $891.1K | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | $250.6K | Mar 27, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $15.71M | Sep 11, 2024 |
| FY2023 | Dec 31, 2022 | $21.41M | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | $1.58M | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | $2.16M | Mar 15, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($30.29M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($16.21M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($18.32M) | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | ($15.38M) | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | ($6.82M) | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | ($11.54M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.24M) | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | ($2.36M) | Mar 27, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.69M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $6.04M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $2.11M | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | $870.0K | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | $19.4K | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | $12.0K | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $21.3K | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | $7.0K | Mar 27, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $153.56M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $74.36M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $78.51M | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | $17.28M | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | $15.27M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $148.2K | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | $1.80M | Mar 27, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.66M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $46.27M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $5.65M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $13.39M | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | $1.08M | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | $693.2K | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.96M | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | $3.31M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.5K | Jun 7, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $107.29M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $68.70M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $65.12M | Mar 2, 2026 |
| FY2023 | Dec 31, 2021 | $15.02M | Sep 11, 2024 |
| FY2022 | Dec 31, 2020 | $14.57M | Jun 26, 2023 |
| FY2020 | Dec 31, 2019 | ($2.81M) | Mar 18, 2021 |
| FY2020 | Dec 31, 2018 | ($1.52M) | Mar 18, 2021 |
| FY2019 | Dec 31, 2017 | ($1.5K) | Mar 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.57M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $55.57M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $55.57M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $55.57M | Sep 11, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($219.16M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($200.48M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($131.94M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($104.06M) | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | ($81.39M) | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | ($53.50M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($28.76M) | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | ($20.38M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($9.87M) | Jun 7, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $737.88M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $78.95M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.06M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $5.31M | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | $16.74M | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | $15.20M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $101.1K | Mar 18, 2021 |
| FY2020 | Dec 31, 2018 | $1.77M | Mar 18, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 26, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 26, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 224.17M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 129.01M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 77.45M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 55.96M | Sep 11, 2024 |
| FY2022 | Dec 31, 2021 | 29.16M | Jun 26, 2023 |
| FY2021 | Dec 31, 2020 | 27.97M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 7.36M | Mar 18, 2021 |
| FY2019 | Dec 31, 2018 | 4.72M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | 943,735 | Jun 7, 2019 |